Eleonora Palluzzi

445 total citations
18 papers, 307 citations indexed

About

Eleonora Palluzzi is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Eleonora Palluzzi has authored 18 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 9 papers in Oncology and 5 papers in Obstetrics and Gynecology. Recurrent topics in Eleonora Palluzzi's work include Ovarian cancer diagnosis and treatment (12 papers), PARP inhibition in cancer therapy (7 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Eleonora Palluzzi is often cited by papers focused on Ovarian cancer diagnosis and treatment (12 papers), PARP inhibition in cancer therapy (7 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Eleonora Palluzzi collaborates with scholars based in Italy. Eleonora Palluzzi's co-authors include Giovanni Scambia, Gabriella Ferrandina, Giacomo Corrado, Vanda Salutari, Maria Vittoria Mattoli, Cláudia Marchetti, Anna Fagotti, Anna Lia Valentini, Francesco Fanfani and Stefano Gentileschi and has published in prestigious journals such as BioMed Research International, Gynecologic Oncology and Critical Reviews in Oncology/Hematology.

In The Last Decade

Eleonora Palluzzi

17 papers receiving 302 citations

Peers

Eleonora Palluzzi

ONCOL

SURGE

Maria M. Rubinstein United States

Pi‐Lin Sung Taiwan

Sayaka Ueno Japan

Beata Maćkowiak-Matejczyk Poland

Inês Vasconcelos Germany

Soshi Kusunoki Japan

Daniela Freitas Brazil

Charles‐André Philip France

A. Paglia Italy

Maria M. Rubinstein United States

Eleonora Palluzzi

107 ×0.6

124 ×1.1

105 ×1.0

ONCOL

34 ×0.6

SURGE

82 ×1.4

Citations per year, relative to Eleonora Palluzzi Eleonora Palluzzi (= 1×) peers Maria M. Rubinstein

Countries citing papers authored by Eleonora Palluzzi

Since Specialization

Citations

This map shows the geographic impact of Eleonora Palluzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Palluzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Palluzzi more than expected).

Fields of papers citing papers by Eleonora Palluzzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Palluzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Palluzzi. The network helps show where Eleonora Palluzzi may publish in the future.

Co-authorship network of co-authors of Eleonora Palluzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Palluzzi. A scholar is included among the top collaborators of Eleonora Palluzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Palluzzi. Eleonora Palluzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Pomati, Giulia, Giacomo Corrado, Eleonora Palluzzi, et al.. (2025). The role of HER2 pathway in vulvar paget’s disease. Critical Reviews in Oncology/Hematology. 214. 104836–104836.

Boccia, Serena Maria, Laura Vertechy, Eleonora Palluzzi, et al.. (2024). Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?. Drug Design Development and Therapy. Volume 18. 2021–2032. 3 indexed citations

Palluzzi, Eleonora, Cláudia Marchetti, Serena Cappuccio, et al.. (2022). Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance. International Journal of Gynecological Cancer. 32(9). 1164–1170. 19 indexed citations

Palluzzi, Eleonora, Giacomo Corrado, Cláudia Marchetti, et al.. (2021). Medical treatment of patients with gynecologic cancer during the COVID-19 pandemic. International Journal of Gynecological Cancer. 31(8). 1154–1158. 1 indexed citations

Marchetti, Cláudia, Andrea Rosati, Francesca De Felice, et al.. (2021). Optimizing the number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma: A propensity-score matching analysis. Gynecologic Oncology. 163(1). 29–35. 15 indexed citations

Marchetti, Cláudia, Eleonora Palluzzi, Serena Cappuccio, et al.. (2021). 242 PARP-inhibitors beyond progression: a new way to manage oligometastatic ovarian cancer recurrence. A215.1–A215. 2 indexed citations

Parisi, Alessandro, Eleonora Palluzzi, Alessio Cortellini, et al.. (2019). First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience. Clinical & Translational Oncology. 22(1). 158–162. 18 indexed citations

Marchetti, Cláudia, Andrea Rosati, Giuseppe Scaletta, et al.. (2019). Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer before olaparib maintenance: Still getting any benefit? A case-control study. Gynecologic Oncology. 155(3). 400–405. 19 indexed citations

Corrado, Giacomo, Eleonora Palluzzi, Carolina Bottoni, et al.. (2019). New medical approaches in advanced ovarian cancer. Minerva Medica. 110(4). 367–384. 5 indexed citations

10.

Nero, Camilla, Anna Fagotti, Gian Franco Zannoni, et al.. (2019). Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes. International Journal of Gynecological Cancer. 29(6). 1064–1071. 3 indexed citations

11.

Ferrandina, Gabriella, Giacomo Corrado, Valerio Gallotta, et al.. (2018). Dose-dense paclitaxel/carboplatin as neo-adjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer: a prospective phase II study. Cancer Chemotherapy and Pharmacology. 83(3). 431–438. 12 indexed citations

12.

Ferrandina, Gabriella, Eleonora Palluzzi, Valerio Gallotta, et al.. (2018). Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study. European Journal of Surgical Oncology. 44(7). 1062–1068. 30 indexed citations

13.

Paris, Ida, Eleonora Palluzzi, Giorgia Garganese, et al.. (2018). Management of BRCA mutation carriers. Translational Cancer Research. 7(S3). S329–S338. 2 indexed citations

14.

Giuliani, Michela, Benedetta Gui, Anna Lia Valentini, et al.. (2017). Early detection of recurrence or progression disease in patients with ovarian cancer after primary debulking surgery. Correlation between CT findings and CA 125 levels. Minerva Obstetrics and Gynecology. 69(6). 538–547. 5 indexed citations

15.

Ferrandina, Gabriella, Ida Paris, Mariagrazia Distefano, et al.. (2017). Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients. International Journal of Gynecological Cancer. 27(6). 1141–1148. 4 indexed citations

16.

Corrado, Giacomo, et al.. (2017). Optimizing treatment in recurrent epithelial ovarian cancer. Expert Review of Anticancer Therapy. 17(12). 1147–1158. 112 indexed citations

17.

Ferrandina, Gabriella, Eleonora Palluzzi, Francesco Fanfani, et al.. (2016). Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature. World Journal of Surgical Oncology. 14(1). 300–300. 47 indexed citations

18.

Bruera, Gemma, Katia Cannita, Eleonora Palluzzi, et al.. (2014). Bioclinical Parameters Driving Decision-Making of Subsequent Lines of Treatment in Metastatic Castration-Resistant Prostate Cancer. BioMed Research International. 2014. 1–7. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact